Cardiotoxicity in Hematopoietic Stem Cell Transplant: Keeping the Beat
This study describes the incidence and type of cardiac events (CE) experienced by autologous and allogeneic hematopoietic stem cell transplant patients over a five-year period at one institution. 9.8% of patients experienced a CE, and those that experienced a CE had an increased risk of death within one year (p
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Julie Kay Baker, Jessica Shank-Coviello, Bin Zhou, Jane Dixon, Ruth McCorkle, Daniel Sarpong, Erin Medoff, Dennis Cooper, Stuart Seropian, Feng Dai Tags: Original Study Source Type: research
More News: Cardiology | Heart | Hematology | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Study | Transplants